Benign breast diseases: Classification, diagnosis, and management

Oncologist

Volumn 11, Issue 5, 2006, Pages 435-449

  Guray, Merih ^a   Sahin, Aysegul A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Benign; Benign breast disease; Developmental abnormalities; Fibrocystic changes; Inflammatory lesions; Neoplasms

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; BREAST ABSCESS; BREAST ADENOMA; BREAST CANCER; BREAST CYST; BREAST DISEASE; BREAST DUCT ECTASIA; BREAST FIBROADENOMA; BREAST HAMARTOMA; BREAST HYPERPLASIA; BREAST LESION; BREAST PAPILLOMA; CANCER GROWTH; CELL DAMAGE; CELL HYPERPLASIA; CELL PROLIFERATION; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISEASE CLASSIFICATION; ECHOMAMMOGRAPHY; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; FAT NECROSIS; FIBROCYSTIC BREAST DISEASE; FOREIGN BODY REACTION; GRANULAR CELL TUMOR; GRANULOMATOSIS; HUMAN; INFLAMMATION; LIPOMA; MAMMOGRAPHY; MASTITIS; METAPLASIA; NIPPLE; PAPILLOMATOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SCLEROSIS; STROMA CELL;

BREAST DISEASES; FEMALE; HUMANS;

EID: 33646857926     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-5-435     Document Type: Review

References (126)

1. Caleffi M, Filho DD, Borghetti K et al. Cryoablation of benign breast tumors: evolution of technique and technology. Breast 2004;13:397-407.
2. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990;12:228-240.
3. Cole P, Mark Elwood J, Kaplan SD. Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol 1978;108:112-120.
4. Hutchinson WB, Thomas DB, Hamlin WB et al. Risk of breast cancer in women with benign breast lesion. J Natl Cancer Inst 1980;65:13-20.
5. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998;122:1053-1055.
6. Sarnelli R, Squartini F. Fibrocystic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 1991;18:271-279.
7. Bartow SA, Pathak DR, Black WC et al. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987;60:2751-2760.
8. Cook MG, Rohan TE. The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Pathol 1985;146:1-15.
9. La Vecchia C, Parazzini F, Franceschi S et al. Risk factors for benign breast disease and their relation with breast cancer risk. Pooled information from epidemiologic studies. Tumori 1985;71:167-178.
10. Donegan WL. Common benign conditions of the breast. In: Donegan WL, Spratt JS, eds. Cancer of the Breast, Fifth Edition. St. Louis, MO: Saunders, 2002:67-110.
11. Shaaban AM, Sloane JP, West CS et al. Histopathologic types of benign breast lesions and risk of breast cancer. Am J Surg Pathol 2002;26:421-430.
12. Morrow M. Pre-cancerous breast lesions: implications for breast cancer prevention trials. Int J Radiat Oncol Biol Phys 1992;23:1071-1078.
13. London SJ, Connolly JL, Schnitt SJ et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992;267:941-944.
14. McDivitt RW, Stevens JA, Lee NC et al. Histologic types of benign breast disease and the risk for breast cancer. Cancer 1992;69:1408-1414.
15. Pfeifer JD, Barr RJ, Wick MR. Ectopic breast tissue and breast-like sweat gland metaplasias: an overlapping spectrum of lesions. J Cutan Pathol 1999;26:190-196.
16. Marshall MB, Moynihan JJ, Frost A et al. Ectopic breast cancer: case report and literature review. Surg Oncol 1994;3:295-304.
17. O'Hara MF, Page DL. Adenomas of the breast and ectopic breast under lactational influences. Hum Pathol 1985;16:707-712.
18. Markopoulos C, Kouskos E, Kontzoglou K et al. Breast cancer in ectopic breast tissue. Eur J Gynaecol Oncol 2001;22:157-159.
19. Schinzel A. Ulnar-mammary syndrome. J Med Genet 1987;24:778-781.
20. Tamiolakis D, Venizelos I, Antoniou C et al. Breast cancer development in a female with Poland's syndrome. Onkologie 2004;27:569-571.
21. Fan W, Huang X, Chen C et al. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 2004;64:5132-5139.
22. Swerdlow AJ, Hermon C, Jacobs PA et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001;65:177-188.
23. Rosen PP, ed. Chapter 2. Abnormalities of mammary growth and development. In: Rosen's Breast Pathology, Second Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:23-27.
24. Foxman B, D'Arcy H, Gillespie B et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002;155:103-114.
25. Michie C, Lockie F, Lynn W. The challenge of mastitis. Arch Dis Child 2003;88:818-821.
26. Dener C, Inan A. Breast abscesses in lactating women. World J Surg 2003;27:130-133.
27. Barbosa-Cesnik C, Schwartz K, Foxman B. Lactation mastitis. JAMA 2003;289:1609-1612.
28. Erhan Y, Veral A, Kara E et al. A clinicopathologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. Breast 2000;9:52-56.
29. Diesing D, Axt-Fliedner R, Hornung D et al. Granulomatous mastitis. Arch Gynecol Obstet 2004;269:233-236.
30. Tewari M, Shukla HS. Breast tuberculosis: diagnosis, clinical features & management. Indian J Med Res 2005;122:103-110.
31. Azlina AF, Ariza Z, Arni T et al. Chronic granulomatous mastitis: diagnostic and therapeutic considerations. World J Surg 2003;27:515-518.
32. van Diest PJ, Beekman WH, Hage JJ. Pathology of silicone leakage from breast implants. J Clin Pathol 1998;51:493-497.
33. Passaro ME, Broughan TA, Sebek BA et al. Lactiferous fistula. J Am Coll Surg 1994;178:29-32.
34. Rosen PP, ed. Chapter 4. Specific infections. In: Rosen's Breast Pathology, Second Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:65-75.
35. Furlong AJ, al-Nakib L, Knox WF et al. Periductal inflammation and cigarette smoke. J Am Coll Surg 1994;179:417-420.
36. Rahal RMS, de Freitas-Junior R, Paulinelli RR. Risk factors for duct ectasia. Breast J 2005;11:262-265.
37. Dixon JM, Ravisekar O, Chetty U et al. Periductal mastitis and duct ectasia: different conditions with different aetiologies. Br J Surg 1996;83:820-822.
38. Sweeney DJ, Wylie EJ. Mammographic appearances of mammary duct ectasia that mimic carcinoma in a screening programme. Australas Radiol 1995;39:18-23.
39. Sakorafas GH. Nipple discharge: current diagnostic and therapeutic approaches. Cancer Treat Rev 2001;27:275-282.
40. Rosai J, ed. Chapter 20. Breast. In: Rosai and Ackerman's Surgical Pathology, Ninth Edition. Philadelphia: Mosby, 2004:1763-1876.
41. Kinoshita T, Yashiro N, Yoshigi J et al. Fat necrosis of breast: a potential pitfall in breast MRI. Clin Imaging 2002;26:250-253.
42. Pullyblank AM, Davies JD, Basten J et al. Fat necrosis of the female breast - Hadfield re-visited. Breast 2001;10:388-391.
43. Silverberg SG, Masood S. The breast. In: Silverberg SG, DeLellis RA, Frable WJ, eds. Principles and Practice of Surgical Pathology and Cytopathology, Third Edition. New York: Churchill-Livingstone, Inc., 1997:575-673.
44. Rosen PP, ed. Chapter 3. Inflammatory and reactive tumors. In: Rosen's Breast Pathology, Second Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:29-63.
45. Love SM, Gelman RS, Silen W. Fibrocystic "disease" of the breast - a non-disease? N Engl J Med 1982;307:1010-1014.
46. Santen RJ, Mansel R. Benign breast disorders. N Engl J Med 2005;353:275-285.
47. Vorherr H. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. Am J Obstet Gynecol 1986;154:161-179.
48. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-151.
49. Dupont WD, Parl FF, Hartmann WH et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-1265.
50. Palli D, Rosselli Del Turco M, Simoncini R et al. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 1991;47:703-706.
51. Hartmann LC, Sellers TA, Frost MH et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-237.
52. Marshall LM, Hunter DJ, Connolly JL et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301.
53. O'Malley FP, Bane AL. The spectrum of apocrine lesions of the breast. Adv Anat Pathol 2004;11:1-9.
54. Houssami N, Irwig L, Ung O. Review of complex breast cysts: implications for cancer detection and clinical practice. ANZ J Surg 2005;75:1080-1085.
55. Venta LA, Kim JP, Pelloski CE et al. Management of complex breast cysts. AJR Am J Roentgenol 1999;173:1331-1336.
56. Vargas HI, Vargas MP, Gonzalez KD et al. Outcomes of sonography-based management of breast cysts. Am J Surg 2004;188:443-447.
57. Lee K, Chan JKC, Gwi E. Tubular adenosis of the breast: a distinctive benign lesion mimicking invasive carcinoma. Am J Surg Pathol 1996;20:46-54.
58. Jensen RA, Page DL, Dupont WD et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989;64:1977-1983.
59. Gill HK, Ioffe OB, Berg WA. When is a diagnosis of sclerosing adenosis acceptable at core biopsy? Radiology 2003;228:50-57.
60. Bodian CA, Perzin KH, Lattes R et al. Prognostic significance of benign proliferative breast disease. Cancer 1993;71:3896-3907.
61. Millis RR, Eusebi V. Microglandular adenosis of the breast. Adv Anat Pathol 1995;2:10-18.
62. Eusebi V, Foschini MP, Betts CM et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast: an immunohistochemical comparison. Am J Surg Pathol 1993;17:99-109.
63. Acs G, Simpson JF, Bleiweiss IJ et al. Microglandular adenosis with transition into adenoid cystic carcinoma of the breast. Am J Surg Pathol 2003;27:1052-1060.
64. Tavassoli FA, ed. Chapter 5. Benign lesions. In: Pathology of the Breast, Second Edition. Stamford, CT: Appleton & Lange, 1999:115-204.
65. Vina M, Wells CA. Clear cell metaplasia of the breast: a lesion showing eccrine differentiation. Histopathology 1989;15:85-92.
66. Tavassoli FA, ed. Chapter 6. Ductal intraepithelial neoplasia. In: Pathology of the Breast, Second Edition. CT: Appleton & Lange, 1999:205-323.
67. Koerner FC. Epithelial proliferations of ductal type. Semin Diagn Pathol 2004;21:10-17.
68. Pinder SE, Ellis IO. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) - current definitions and classification. Breast Cancer Res 2003;5:254-257.
69. Webb PM, Byrne C, Schnitt SJ et al. Family history of breast cancer, age, and benign breast disease. Int J Cancer 2002;100:375-378.
70. Page DL, Dupont WD, Rogers LW et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985;55:2698-2708.
71. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518-529.
72. Collins L, Baer H, Tamimi R et al. Magnitude and laterality of breast cancer risk in women with atypical hyperplasia of ductal and lobular types. Lab Invest 2006;86(suppl 1):24A.
73. Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 1989;20:723-725.
74. Page DL, Schuyler PA, Dupont WD et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003;361:125-129.
75. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol 2003;10:113-124.
76. Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia - classification, pathologic features and clinical significance. Breast Cancer Res 2003;5:263-268.
77. Nasser SM. Columnar cell lesions: current classification and controversies. Semin Diagn Pathol 2004;21:18-24.
78. Kennedy M, Masterson AV, Kerin M et al. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003;56:721-724.
79. Patterson JA, Scott M, Anderson N et al. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol 2004;30:1065-1068.
80. Rabban JT, Sgroi DC. Sclerosing lesions of the breast. Semin Diagn Pathol 2004;21:42-47.
81. Nielsen M, Christensen L, Andersen J. Radial scars in women with breast cancer. Cancer 1987;59:1019-1025.
82. Jacobs TW, Byrne C, Colditz G et al. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999;340:430-436.
83. Fasih T, Jain M, Shrimankar J et al. All radial scars/complex sclerosing lesions seen on breast screening mammograms should be excised. Eur J Surg Oncol 2005;31:1125-1128.
84. Oyama T, Koerner FC. Noninvasive papillary proliferations. Semin Diagn Pathol 2004;21:32-41.
85. MacGrogan G, Tavassoli FA. Central atypical papillomas of the breast: a clinicopathological study of 119 cases. Virchows Arch 2003;443:609-617.
86. Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 2004;122:440-443.
87. Ivan D, Selinko V, Sahin AA et al. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol 2004;17:165-171.
88. Ali-Fehmi R, Carolin K, Wallis T et al. Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 2003;34:234-239.
89. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 1992;135:619-631.
90. Levshin V, Pikhut P, Yakovleva I et al. Benign breast lesions and cancer of the breast. Eur J Cancer Prev 1998;7(suppl 1):S37-S40.
91. Page DL, Salhany KE, Jensen RA et al. Subsequent breast carcinoma risk after biopsy with atypia in breast papilloma. Cancer 1996;78:258-266.
92. Pacilli M, Sebire NJ, Thambapillai E et al. Juvenile papillomatosis of the breast in a male infant with Noonan syndrome, café au lait spots, and family history of breast carcinoma. Pediatr Blood Cancer 2005;45:991-993.
93. Bazzocchi F, Santini D, Martinelli G et al. Juvenile papillomatosis (epitheliosis) of the breast: a clinical and pathologic study of 13 cases. Am J Clin Pathol 1986;86:745-748.
94. Rosen PP, ed. Chapter 39. Breast tumors in children. In: Rosen's Breast Pathology, Second Edition. Philadelphia: Lippincott Williams & Wilkins, 2001:729-748.
95. Haj M, Weiss M, Herskovits T. Diabetic sclerosing lymphocytic lobulitis of the breast. J Diabetes Complications 2004;18:187-191.
96. Camuto PM, Zetrenne E, Ponn T. Diabetic mastopathy: a report of 5 cases and a review of the literature. Arch Surg 2000;135:1190-1193.
97. Baratelli GM, Riva C. Diabetic fibrous mastopathy: sonographic-pathologic correlation. J Clin Ultrasound 2005;33:34-37.
98. Castro CY, Whitman GJ, Sahin AA. Pseudoangiomatous stromal hyperplasia of the breast. Am J Clin Oncol 2002;25:213-216.
99. Pruthi S, Reynolds C, Johnson RE et al. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J 2001;7:434-439.
100. Mercado CL, Naidrich SA, Hamele-Bena D et al. Pseudoangiomatous stromal hyperplasia of the breast: sonographic features with histopathologic correlation. Breast J 2004;10:427-432.
101. El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast 2003;12:302-307.
102. Hughes LE, Mansel RE, Webster DJT. Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 1987;2:1316-1319.
103. Tavassoli FA, ed. Chapter 11. Biphasic tumors. In: Pathology of the Breast, Second Edition. Stamford, CT: Appleton & Lange, 1999:571-631.
104. Kleer CG, Tseng MD, Gutsch DE et al. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Mod Pathol 2002;15:759-764.
105. Moore T, Lee AHS. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast. Histopathology 2001;38:62-67.
106. Franco N, Arnould L, Mege F et al. Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer. Arch Surg 2003;138:291-295.
107. Valdes EK, Boolbol SK, Cohen JM et al. Malignant transformation of a breast fibroadenoma to cystosarcoma phyllodes: case report and review of the literature. Am Surg 2005;71:348-353.
108. Geisler DP, Boyle MJ, Malnar KF et al. Phyllodes tumors of the breast: a review of 32 cases. Am Surg 2000;66:360-366.
109. Chen WH, Cheng SP, Tzen CY et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005;91:185-194.
110. Carter BA, Page DL, Schuyler P et al. No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Cancer 2001;92:30-36.
111. Shabtai M, Saavedra-Malinger P, Shabtai EL et al. Fibroadenoma of the breast: analysis of associated pathological entities - a different risk marker in different age groups for concurrent breast cancer. Isr Med Assoc J 2001;3:813-817.
112. Graf O, Helbich TH, Fuchsjaeger MH et al. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology 2004;233:850-856.
113. Wechselberger G, Schoeller T, Piza-Katzer H. Juvenile fibroadenoma of the breast. Surgery 2002;132:106-107.
114. Lanng C, Eriksen BO, Hoffmann J. Lipoma of the breast: a diagnostic dilemma. Breast 2004;13:408-411.
115. Reeves ME, Tabuenca A. Lactating adenoma presenting as a giant breast mass. Surgery 2000;127:586-588.
116. Baker TP, Lenert JT, Parker J et al. Lactating adenoma: a diagnosis of exclusion. Breast J 2001;7:354-357.
117. Soo MS, Dash N, Bentley R et al. Tubular adenomas of the breast: imaging findings with histologic correlation. AJR Am J Roentgenol 2000;174:757-761.
118. Montemarano AD, Sau P, James WD. Superficial papillary adenomatosis of the nipple: a case report and review of the literature. J Am Acad Dermatol 1995;33:871-875.
119. Gatti G, Mazzarol G, Simsek S et al. Breast hamartoma: a case report. Breast Cancer Res Treat 2005;89:145-147.
120. Herbert M, Sandbank J, Liokumovich P et al. Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases. Histopathology 2002;41:30-34.
121. Tse GMK, Law BKB, Ma TKF et al. Hamartoma of the breast: a clinicopathological review. J Clin Pathol 2002;55:951-954.
122. Montagnese MD, Roshong-Denk S, Zaher A et al. Granular cell tumor of the breast. Am Surg 2004;70:52-54.
123. Ilvan S, Ustundag N, Calay Z et al. Benign granular-cell tumour of the breast. Can J Surg 2005;48:155-156.
124. Balzan SMP, Farina PS, Maffazzioli L et al. Granular cell breast tumour: diagnosis and outcome. Eur J Surg 2001;167:860-862.
125. Chetty R, Kalan MR. Malignant granular cell tumor of the breast. J Surg Oncol 1992;49:135-137.
126. Adeniran A, Al-Ahmadie H, Mahoney MC et al. Granular cell tumor of the breast: a series of 17 cases and review of the literature. Breast J 2004;10:528-531.